Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer
Media Release COPENHAGEN, Denmark; October 18, 2025 Updated data from the Phase…
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
Vamikibart is the first non-steroid targeted therapy designed to address inflammation driving…
Jiuzi Holdings, Inc. (JZXN) Secures 100 Bitcoin via Private Placement, Signaling New Phase in Crypto Treasury Deployment
HANGZHOU, China, Oct. 13, 2025 /PRNewswire/ -- Jiuzi Holdings, Inc. (NASDAQ: JZXN,…
The 138th Canton Fair is Set to Open in Guangzhou on October 15
GUANGZHOU, China, Oct. 13, 2025 /PRNewswire/ -- The 138th China Import and…
Berlin Heals Holding AG Successfully Completes Enrollment in Phase I of the CMIC-III Less Invasive Study
Completed Enrollment in First-In-Human Phase I study of Less Invasive Approach Expected…
Rwanda Celebrates Completion of Smart Education Project and DigiTruck Launch
KIGALI, Rwanda, Oct. 6, 2025 /PRNewswire/ -- Huawei and Rwanda's Ministry of Education…
Spyre Therapeutics Announces Poster Presentations at United European Gastroenterology Week (UEGW) 2025
October 05, 2025 09:00 ET | Source: Spyre Therapeutics, Inc. WALTHAM, Mass.,…
Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX),…
FIA: After announcing her candidacy, Laura Villars reaches out to all member clubs
GENEVA, Sept. 24, 2025 /PRNewswire/ -- Just days after officially announcing her candidacy…
LANZAJET AND KAZMUNAYGAS (KMG) ANNOUNCE KAZAKHSTAN’S FIRST SUSTAINABLE AVIATION FUEL PROJECT PASSES MAJOR MILESTONE AND ADVANCES TO ENGINEERING AND DESIGN PHASE
As part of New York Climate Week, LanzaJet's CEO addressed the President…